Afinitor www.oncologyonline.net/?q=AfinitorTreatment with Everolimus ( Afinitor ) prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma who have ...Enobosarmwww.oncologyonline.net/?q=EnobosarmA randomised, double-blind, placebo controlled phase IIB trial has shown that treatment with Enobosarm, a non-steroidal selective androgen receptor modulator ...Vorinostat www.oncologyonline.net/?q=VorinostatOn 20 September 2010, orphan designation was granted by the European Commission for Vorinostat for the treatment of malignant mesothelioma.Malignant ...Xofigowww.oncologyonline.net/?q=XofigoThe FDA ( Food and Drug Administration ) has approved Xofigo ( Radium Ra 223 dichloride; Radium-223 ) to treat men with symptomatic late-stage ...Zactima www.oncologyonline.net/?q=ZactimaAstraZeneca announced today that it has withdrawn the regulatory submissions for the use of ZACTIMA ( Vandetanib ) 100mg in combination with chemotherapy ...Ramucirumab www.oncologyonline.net/?q=RamucirumabThe results from the Phase III REGARD trial of Ramucirumab as a single agent in patients with advanced gastric cancer who have had disease progression after ...Nivolumabwww.oncologyonline.net/?q=NivolumabBristol-Myers Squibb has announced long-term follow-up results ( median follow up of 20.3 months ) from the lung cancer cohort ( n=129 ) of the expanded ...Gefitinib www.oncologyonline.net/?q=GefitinibHigh copy number of the epidermal growth factor receptor ( EGFR ) may be an effective predictor of Gefitinib ( Iressa ) efficacy in non–small-cell lung cancer.
Cancer News & Drugs
Afinitor www.oncologyonline.net/?q=AfinitorTreatment with Everolimus ( Afinitor ) prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma who have ...Enobosarmwww.oncologyonline.net/?q=EnobosarmA randomised, double-blind, placebo controlled phase IIB trial has shown that treatment with Enobosarm, a non-steroidal selective androgen receptor modulator ...Vorinostat www.oncologyonline.net/?q=VorinostatOn 20 September 2010, orphan designation was granted by the European Commission for Vorinostat for the treatment of malignant mesothelioma.Malignant ...Xofigowww.oncologyonline.net/?q=XofigoThe FDA ( Food and Drug Administration ) has approved Xofigo ( Radium Ra 223 dichloride; Radium-223 ) to treat men with symptomatic late-stage ...Zactima www.oncologyonline.net/?q=ZactimaAstraZeneca announced today that it has withdrawn the regulatory submissions for the use of ZACTIMA ( Vandetanib ) 100mg in combination with chemotherapy ...Ramucirumab www.oncologyonline.net/?q=RamucirumabThe results from the Phase III REGARD trial of Ramucirumab as a single agent in patients with advanced gastric cancer who have had disease progression after ...Nivolumabwww.oncologyonline.net/?q=NivolumabBristol-Myers Squibb has announced long-term follow-up results ( median follow up of 20.3 months ) from the lung cancer cohort ( n=129 ) of the expanded ...Gefitinib www.oncologyonline.net/?q=GefitinibHigh copy number of the epidermal growth factor receptor ( EGFR ) may be an effective predictor of Gefitinib ( Iressa ) efficacy in non–small-cell lung cancer.